<DOC>
	<DOCNO>NCT01494155</DOCNO>
	<brief_summary>A standard treatment patient pancreatic cancer standard photon radiation combination chemotherapy drug , capecitabine . In research study investigator use standard photon radiation different type radiation therapy call proton beam radiation add hydroxychloroquine use combination capecitabine . In research study , investigator look determine proton photon beam radiation combination hydroxychloroquine capecitabine effective control cancer growth .</brief_summary>
	<brief_title>Short Course Radiation Therapy With Proton Photon Beam Capecitabine Hydroxychloroquine Resectable Pancreatic Cancer</brief_title>
	<detailed_description>Subjects treat cycle 28 day . Hydroxychloroquine take orally , daily day surgery resume surgery study end . Capecitabine take orally , daily . Proton photon radiation treatment start Week 2 deliver daily ( 5 day row , weekend holiday ) . Radiation treatment give outpatient basis Francis H. Burr Proton Center Clark Center Radiation Oncology Massachusetts General Hospital . The following test perform weekly : physical exam , routine blood test , optional blood test eye exam every 3 month take hydroxychloroquine . Subjects surgery ( time Weeks 5 9 ) surgery resume take hydroxychloroquine . Subjects follow visit every 3 month include : physical exam , routine blood test , eye exam , tumor assessment chest abdominal-pelvic CT scan MRI ( every 6 month first 2 year yearly year 3-5 ) .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<criteria>Cytologic histologic proof pancreatic ductal carcinoma Life expectancy &gt; 3 month Adequate organ marrow function Evidence metastatic disease Pregnant breastfeeding Tumors body tail pancreas Serious concomitant systemic disorder significant cardiac pulmonary morbidity ( e.g . congestive heart failure , symptomatic coronary artery disease cardiac arrhythmia well controlled medication ) myocardial infarction within last 12 month , ongoing infection manifest fever Prior chemotherapy radiation treatment patient 's pancreatic tumor Diagnosis invasive carcinoma ( except basal cell carcinomas/squamous cell carcinoma skin ) last 5 year . Carcinoma insitu allow . Other serious uncontrolled medical condition Lack physical integrity upper gastrointestinal tract malabsorption syndrome Known , exist uncontrolled coagulopathy Prior systemic fluoropyrimidine therapy ( unless give adjuvant set complete least 6 month earlier ) . Prior unanticipated severe reaction fluoropyrimidine therapy , know hypersensitivity 5fluorouracil know DPD deficiency Participation investigational drug study within 4 week precede start study treatment History uncontrolled seizure , central nervous system disorder , psychiatric disability Major surgery , exclude laparoscopy , within 4 week start study treatment , without complete recovery Currently take cimetidine Receiving study agent History allergic reaction attribute compound similar chemical biologic composition capecitabine HCQ Already take HCQ chloroquine diagnosis History Grade 3 great retinopathy keratitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>resectable pancreatic cancer</keyword>
	<keyword>pancreaticoduodenectomy</keyword>
</DOC>